HHHHoward Hughes Holdings Inc.
Industry Holding co. Updated 25 Sep 2026
The idea
At 1.00x book HHH is no longer a pure land company: since 2026-06-04 it owns a five-year-old Bermuda specialty insurer (40% of assets) of which a Pershing Square fund's $1.0bn preferred takes up to 49%, whose float Pershing Square now manages without an extra fee and moved within weeks from bonds to a concentrated stock book (32% at 2026-06-30, ~40% by August, target >50%). S&P cut the insurer to BBB on the change of parent [search-summary]. The land bank (MPC EBT $349m → $476m, 2024 → 2025) is being liquidated on purpose to fund it; the base case is book growth, not a re-rating.
Events to watch
- Annual meeting 2026-09-30
- Q3 results ~2026-11-05 to -11-10 (DERIVED from cadence) — Vantage capital contributions and the equity sleeve against $1.55bn of net reserves
- FY2026 10-K (Feb–Mar 2027) with Vantage's first loss-development table
- any A.M. Best action
- any takedown of the 2026-08-14 universal shelf
- trailing MPC EBT against the 2024 $349.1m
How we got the target
Dossier model table (HHH/dossier-2026-09-23.md §5), book value per share × price-to-book, because the company itself has moved to NAV-style KPIs and has no stable earnings line: base 1.00x ~$78 BVPS (2026-06-30 BVPS $66.39 plus ~$5.5/share a year retained, no issuance); bear 0.75x ~$64 (MPC EBT back to the 2024 ~$350m, Vantage adverse development, a 25% fall in a ~$1.5bn equity sleeve, about half of it borne by the Pershing preferred); bull 1.40x ~$80. No dividend. The company's own $104 'conservative' value is not used. Price is market data's 2026-09-22 close (NYSE:HHH), fetched 2026-09-23. Time frame: mid-2028 (Q2 2028 book).
Target: from the research notes. Prices: market data get_latest_stock_price, close of 2026-09-22 (fetched 2026-09-23)
What would prove it wrong
5 warning signsAdverse prior-year development for Vantage in the FY2026 10-K loss-development disclosure.
A.M. Best places Vantage under review or moves the outlook to stable/negative.
Vantage cash plus short Treasuries below net claim reserves at a quarter-end ($1.55bn net at 2026-06-30).
Trailing four-quarter MPC EBT below $349.1m (the 2024 level).
Primary equity issued off the 2026-08-14 S-3ASR below the latest reported BVPS ($66.39 at 2026-06-30).
How far along
10 of 10 steps done
Next step
read the FY2026 10-K (Feb–Mar 2027) for Vantage's first loss-development table before anything else, then the equity-sleeve size against net reserves ($1.55bn at 2026-06-30). Before that, the Q3 10-Q (~2026-11-05/-10): Vantage capital contributions, the equity sleeve's share of invested assets, and whether the S&P action is disclosed.
Needs your decision
S6 product test / expert call, S7 conviction.
Failed checks
none. S8 is closed conservative (added 2026-09-25) and S2's capital-allocation verdict is neutral, so this backfill adds no kill criterion (§25 requires one only for an over-promiser or a capital destroyer). ⚠️ Monitoring changed: annual guidance was withdrawn on 2026-05-08, so the segment guides the last S8 rows were scored on no longer exist; S9's triggers and the Tier 0 filing sweep are now the whole apparatus. S0 standard 3/4; the §4.3 second reading on the insurer is 0/2 with two tests not scorable — the insurer is too young and too new to HHH's filings, and the two scorable tests fail on structure. ⚠️ Dodge thread: capital allocation between the land and the insurer went unanswered with a number in Q1 (BMO) and Q2 (individual investor) — two quarters, S9 trigger added.
Who runs it
The Front OfficeStep by step
- S0How it does as AI gets cheapDone
lens applied (cluster: Additions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23)
standard AI-surplus four (holding_co), lens 3/4: distribution lock-in 1 (sole seller of land inside its MPCs, ~101,000 gross acres), unscrapeable data 0 (the insurer's own 10-Q calls its loss history "a thin historical data set"; land prices are public), liability absorption 1 ($2.12bn claim reserves.
Full notes
MUD/SID-financed infrastructure), bottleneck 1 (entitled land; licences and ratings). PLUS §4.3 second reading on Vantage (40% of assets since 2026-06-04): 0/2 applicable, 2 n/a — reserve honesty and cycle edge not scorable (no loss triangle yet; one disclosed quarter had $19m adverse PYD), capital 0 (S&P cut Vantage to BBB and withdrew [search-summary]. AdVantage sidecars), no-dilution 0 (bought with $900m of new HHH stock and a $1.0bn Pershing preferred taking up to 49% of the insurer). Surplus: the land keeps it, the insurer passes it on. Falsifier: trailing-4Q MPC EBT < $349.1m (2024 level). Liquidity: ADV $41.6m/day (21 sessions to 2026-09-22, market data NYSE:HHH). P/B 1.00, P/TBV 1.28. Re-tag: none recommended now (see cluster file §2).
- S1Where the idea came fromDone
watchlist (owner, 2026-09-23 addition, WATCHLIST_PLAN.md §24). No Tier 0 promotion. No board claim rows.
- S2Quick deal-breaker checkDone
survives. No corporate maturity before 2029 after the Feb 2026 refinancing. $2.6bn cash. MPC EBT $349.1m → $476.1m (2024 → 2025); operating cash flow $396.6m / $462.4m (2024/2025)
Full notes
Share count +8% over five years (55.1m → 59.7m; buybacks 2021-22, +9.0m to Pershing at $100 in 2025).
⚠️ Consolidated net debt ($2.85bn) nets $1.9bn of Vantage float the parent cannot freely use; ex-Vantage ~$4.75bn, ~6.4x NOI + MPC EBT. Certain property-level covenants not met (cash trapped, per 10-Q). 2023 net loss −$551.8m. · capital allocation (added 2026-09-25): NEUTRAL. 2021-2025 operating cash flow $641.8m (negative in 2021 and 2023 — condo construction runs through operating for a developer), real-estate development $1,198.1m, buybacks $485.0m, no dividend ever, no cash acquisition (Vantage closed 2026-06-04 for stock and a preferred). Bought at ~$95, sold at $100: treasury 6,424,276 shares at a cumulative $611.0m = $95.11 average, 79% of it spent 2021-22 — ~32% underwater at $64.58 (2026-09-24) — against 9.0m shares issued to Pershing at $100.00 versus $55.40 of book, which lifted BVPS 14.8% to $63.59. ROIC 2.2% / 6.1% / 3.5% (2023-25), nearer 1.9% in 2025 once capitalised interest is expensed; BVPS $71.09 (2022) → $63.59 (2025), still below its 2022 level after the $672.5m Seaport impairment. Not compounds, not destroys. Balance-sheet series is four years, not five — this CIK begins at 2022-12-31.
- S3Reading the company's reportsDone
(gate-minimum)
FY2025 10-K Items 1, 1A, 7. Q2 2026 10-Q Notes 1-4, MD&A, Item 3, Part II Item 1A (new insurance risk factors); 2026 DEF 14A; 8-Ks 2025-05-06, 2025-12-18, 2026-02-04, 2026-02-17, 2026-04-21, 2026-06-05. S-3ASR 2026-08-14.
Full notes
Q1 and Q2 2026 transcripts (Equibles), read Q&A-first. Three disclosed risks with locators: Pershing Square control, the strategy shift/Vantage, housing. Red flags: none serious — no NT filings, 10-K/As are Part III only, KPMG since 2022, no comment letters since 2017. Bonus still paid on real-estate metrics only. Three dodges logged below. · EQ (added 2026-09-25): 3 flags + 1 note. (1) 46.7% of all interest incurred is capitalised — $148.8m in 2025 against $169.9m expensed, and 120% of net income ($123.9m); 41.1% / 47.9% / 46.7% across 2023-25. Ordinary development accounting, flagged for its size: the earnings line is decided as much by the capitalisation rate as by what the assets earn. (2) Adjusted Operating Cash Flow — the metric guidance is given on — is built on the post-capitalisation interest line, so that $148.8m never enters it. AOCF $446.4m in 2025 against $123.9m of GAAP net income. (3) Guided cash G&A excludes the Pershing Square variable fee (it includes the $15m base fee), on the same line that missed its 2025 guide by 26%. Note: adjusted condo gross profit defines out Waiea remediation and settlement costs ($15.1m in 2024, nil in 2025). Clean: SBC 1.3% of revenue, accruals −3.4% of assets, OCF/NI 3.7x. Sector test not yet possible — Vantage has no loss-development table in HHH's filings; one quarter of $19m adverse PYD is not a series, and the FY2026 10-K is the first checkable point.
- S4Rivals and suppliersDone
(cluster: Additions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23)
land: pricing power inside the MPC, capped by home affordability; insurance: price-taker via brokers (WTW 11.9%, Howden 10.3%) in a softening cycle.
- S5Who owns the stockDone
Pershing Square 27,852,064 (46.6%; 47% ownership cap, 40% voting cap). 13F Q2: Wells Fargo 1.81m (−1.25m), BlackRock 1.62m, Citadel, Jane Street, Susquehanna adding.
Full notes
Insiders ex-Pershing ~1.0%; pattern immaterial (two small buys, four small sales). Short interest 3.54m (2026-08-31), rising five settlements, = 11.1% of the non-Pershing float, 8.3 days. Shelf: unlimited S-3ASR 2026-08-14, no takedown; no ATM found.
⚠️ Q2 13F ingestion incomplete (195 vs 288 filers; Vanguard/Dimensional not in — not exits).
⚠️ The tool's
exitedlabel on Pershing Square Capital Mgmt = re-attribution to Pershing Square Inc., not an exit.⚠️
⚠️ Sixth Street row is NOT a holding (duplicate of Schwab IM).
- S6What workers and customers sayDone
(cluster: Additions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23)
S&P cut Vantage to BBB and withdrew. A.M. Best affirmed A- positive [search-summary]; short interest 11% of the float outside Pershing. Product test / expert call open OPEN (user)
- S7The case for it, and pricesDone
(cluster: Additions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23)
five kill criteria; variant: the unit of value is what Pershing Square earns on Vantage's float, half of which is shared with a Pershing preferred.
Full notes
Conviction open OPEN (user) · valuation (bear/base/bull; moved from S8 2026-09-23): P/B model to mid-2028: bear ~$48 (0.75x ~$64), base ~$78 (1.00x ~$78), bull ~$112 (1.40x ~$80). ADV $41.6m.
- S8Do the bosses keep their word?Done
conservative
9 rows, written 2026-09-25 from all eight archived calls and the FY2023/FY2024/FY2025 outlook releases. 6 beat, 2 met, 1 missed, 1 withdrawn. Every row belongs to executives still in the chair (O'Reilly CEO, Olea CFO throughout.
Full notes
Ackman Executive Chairman from 2025-05-05) — no departed rows, which is unusual in this repo. The guidance is set to be beaten and management says so: FY2024 MPC EBT guided to fall 10-15% (mid ~$300m) and landed at $349.1m; FY2024 NOI guided +1-4% and landed above the range at $257.0m. FY2025 MPC EBT guided +5-10% (mid ~$375m) and landed at $476.1m; FY2025 NOI guided flat-to-+4% and landed at $276.3m; FY2025 adjusted operating cash flow guided $320-375m and landed at $446.4m; condo revenue ~$375m with no profit → $370.2m and $0.7m; year-end cash ~$600m → $605.7m excluding the unguided Pershing issue.
⚠️ The one miss is the cost line and it is big: cash G&A guided to IMPROVE to $76-86m came in at $108.6m — 26% over the top, 31% above the prior year — and the 2026 replacement guide excludes the Pershing Square variable fee.
⚠️
⚠️ The record ends here: the whole FY2026 guidance set (AOCF $415-465m, MPC EBT $343-391m, NOI $279-290m, condo revenue $720-750m, cash G&A $82-92m) was published 2026-02-19 and WITHDRAWN on 2026-05-08 by the Executive Chairman, not the CFO who gave it, for the Vantage transaction — so no future pass can score a first guide against a result on this name. Counting that withdrawal as its five metric guides the record is 13 rows and 46% withdrawn-or-missed, just under the half that would read over-promises; both counts are in the dossier because the verdict is sensitive to which is used.
- S9What to watch nextDone
trigger written; next earnings ~2026-11-05 to -11-10 (DERIVED from cadence); annual meeting 2026-09-30. Tier 0 EDGAR sweep (cik 1981792)
Full notes
Leading indicator: Pershing Square's published portfolio performance (the Vantage sleeve holds largely the same names).
Sources and notes
Sources 15 documents
- Full notes, 25 Sep 2026
- Full notes, 23 Sep 2026
- Additions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23
- EDGAR filings CIK 1981792
| Short name | Document | Where it came from | Read on |
|---|---|---|---|
| 10K-2025 | Howard Hughes Holdings 10-K for FY2025, filed 2026-02-19 | https://www.sec.gov/Archives/edgar/data/1981792/000162828026009710/hhh-20251231.htm | 2026-09-23 |
| 10Q-Q2-26 | Howard Hughes Holdings 10-Q for the quarter ended 2026-06-30, filed 2026-08-05 | https://www.sec.gov/Archives/edgar/data/1981792/000162828026053324/hhh-20260630.htm | 2026-09-23 |
| DEF14A-26 | Howard Hughes Holdings DEF 14A filed 2026-08-19 (annual meeting 2026-09-30) | https://www.sec.gov/Archives/edgar/data/1981792/000110465926098808/tm263319-1_def14a.htm | 2026-09-23 |
| 8K-PS-25 | 8-K filed 2025-05-06 — Pershing Square share purchase, services, shareholder, standstill and registration-rights agreements | https://www.sec.gov/Archives/edgar/data/1981792/000110465925044710/tm2513988d1_8k.htm | 2026-09-23 |
| 8K-VANTAGE-SPA-25 | 8-K filed 2025-12-18 — purchase agreement for Vantage Group Holdings, Ltd. | https://www.sec.gov/Archives/edgar/data/1981792/000110465925122577/tm2533845d1_8k.htm | 2026-09-23 |
| 8K-NOTES-26 | 8-K filed 2026-02-17 — $1bn of HHC 5.875% 2032 and 6.125% 2034 senior notes | https://www.sec.gov/Archives/edgar/data/1981792/000110465926016423/tm264897d3_8k.htm | 2026-09-23 |
| 8K-GRANDISSON-26 | 8-K filed 2026-04-21 — Marc Grandisson warrants and board appointment | https://www.sec.gov/Archives/edgar/data/1981792/000110465926046045/tm2612268d1_8k.htm | 2026-09-23 |
| 8K-VANTAGE-CLOSE-26 | 8-K filed 2026-06-05 — Vantage closing and Series A preferred issued to Pershing Square Holdings | https://www.sec.gov/Archives/edgar/data/1981792/000110465926071029/tm2616794d1_8k.htm | 2026-09-23 |
| S3ASR-26 | S-3ASR universal shelf filed 2026-08-14 | https://www.sec.gov/Archives/edgar/data/1981792/000110465926097326/tm2622238-1_s3asr.htm | 2026-09-23 |
| 13F-Q2-26 | Institutional holders by manager, 13F report date 2026-06-30 (ingestion incomplete — see edge notes) | python ledger/research/tools/threespread.py holders HHH | 2026-09-23 |
| FORM4-2025-26 | Form 4 filings 2025-09-23 to 2026-09-23 (54), incl. 0001104659-25-124903 (Sellers P), 0001104659-26-028623 (Valane P), 0001140361-26-016490 (Pershing J), 0001140361-26-024482 (PSH preferred) | python ledger/research/tools/threespread.py insiders HHH --days 365 --limit 200, then each filing's XML on www.sec.gov | 2026-09-23 |
| CALL-Q1-26 | Q1 2026 earnings call transcript, 2026-05-08 (Equibles, machine speech-to-text; paraphrase only) | Equibles GetEarningsCallTranscript HHH FY2026 Q1 | 2026-09-23 |
| CALL-Q2-26 | Q2 2026 earnings call transcript, 2026-08-06 (Equibles, machine speech-to-text; paraphrase only) | Equibles GetEarningsCallTranscript HHH FY2026 Q2 | 2026-09-23 |
| SEARCH-SP-26 | [search-summary] Trade press on S&P's downgrade and withdrawal of Vantage's rating (The Insurer 2026-06-15; Royal Gazette 2026-06-16; Intelligent Insurer) | WebSearch 2026-09-23: Howard Hughes Holdings Vantage S&P rating action 2026 | 2026-09-23 |
| CLUSTER-HHH | Additions 2026-09-23 cluster pass, HHH member | ledger/research/_clusters/cluster-additions-HHH-2026-09-23.md | 2026-09-23 |
Links to other companies 34 links
| From | Link | To | Date | Where it says so |
|---|---|---|---|---|
| Pershing Square Capital Management, L.P. / Pershing Square Inc. and affiliates | holds | HHH | 2026-08-17 | DEF14A-26 — Security Ownership of Directors, Executive Officers and Certain Beneficial Holders, footnote (1) |
| Pershing Square Capital Management, L.P. / Pershing Square Inc. and affiliates | governance structure | HHH | 2025-05-05 | 8K-PS-25 — Item 1.01, Standstill Agreement, Ownership Cap |
| Pershing Square Capital Management, L.P. / Pershing Square Inc. and affiliates | context | HHH | 2025-05-05 | 8K-PS-25 — Item 1.01, Services Agreement |
| Pershing Square Capital Management, L.P. / Pershing Square Inc. and affiliates | context | Vantage general-account equity securities portfolio ($1.08bn at 2026-06-30) | 2026-06-30 | 10Q-Q2-26 — Note 3 - Pershing Square, final paragraph |
| Vantage general-account equity securities portfolio ($1.08bn at 2026-06-30) | context | HHH | 2026-06-30 | 10Q-Q2-26 — Item 3, Equity Price Risk |
| Pershing Square Holdings, Ltd. (Guernsey; a Pershing Square fund) | holds | HHH Series A Non-voting Exchangeable Perpetual Preferred Stock ($1.0bn, 140,000 shares) | 2026-06-04 | 8K-VANTAGE-CLOSE-26 — Item 1.01, Certificate of Designations — Exchange Right |
| HHH | issuer of | HHH Series A Non-voting Exchangeable Perpetual Preferred Stock ($1.0bn, 140,000 shares) | 2026-06-04 | 8K-VANTAGE-CLOSE-26 — Item 1.01, Certificate of Designations — Call Option |
| HHH | acquired | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2025-12-17 | 8K-VANTAGE-SPA-25 — Item 1.01, Purchase Agreement |
| Carlyle Partners VII Cayman Holdings V, L.P. (Vantage seller) | context | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2025-12-17 | 8K-VANTAGE-SPA-25 — Item 1.01, parties to the Purchase Agreement |
| H&F Vantage Aggregator, L.P. (Hellman & Friedman; Vantage seller) | context | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2025-12-17 | 8K-VANTAGE-SPA-25 — Item 1.01, parties to the Purchase Agreement |
| Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | context | HHH | 2026-06-30 | 10Q-Q2-26 — Part II Item 1A, Risks Related to Our Insurance Operations, first factor |
| AdVantage Reinsurance Bermuda Ltd. (segregated-accounts third-party capital vehicle) | financing partner | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-30 | 10Q-Q2-26 — Note 1, AdVantage Reinsurance Bermuda Ltd. |
| Willis Towers Watson (broker) | channel concentration | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-30 | 10Q-Q2-26 — Note 1, Premiums Receivable / broker concentration table |
| Howden (broker) | channel concentration | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-30 | 10Q-Q2-26 — Note 1, Premiums Receivable / broker concentration table |
| A.M. Best | context | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-30 | 10Q-Q2-26 — Part II Item 1A, A.M. Best rating factor |
| S&P Global Ratings | event | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-15 | SEARCH-SP-26 — search result summaries: The Insurer 2026-06-15, Royal Gazette 2026-06-16 |
| Delaware Department of Insurance | regulator of | Vantage Group Holdings, Ltd. (Bermuda specialty insurer and reinsurer; subsidiary since 2026-06-04) | 2026-06-30 | 10Q-Q2-26 — MD&A, Insurance-Related Statutory Capital and Dividend Restrictions |
| William A. Ackman | officer of | HHH | 2025-05-05 | 8K-PS-25 — Item 1.01, Shareholder Agreement, Executive Chairman |
| Ryan Israel | officer of | HHH | 2026-02-12 | 10K-2025 — Item 1A, Pershing Square risk factor |
| David O'Reilly | officer of | HHH | 2026-08-17 | DEF14A-26 — CD&A, 2025 Annual Compensation Mix; ownership table |
| Carlos A. Olea | officer of | HHH | 2026-08-17 | DEF14A-26 — CD&A, Key Responsibilities |
| Marc Grandisson | director of | HHH | 2026-04-19 | 8K-GRANDISSON-26 — Item 5.02 |
| Marc Grandisson | holds | Warrants over 1,131,273 HHH shares at $100, exercisable 2030-04-20 | 2026-04-20 | 8K-GRANDISSON-26 — Item 1.01 |
| Marc Grandisson | context | Arch Capital Group Ltd. | 2026-08-06 | CALL-Q2-26 — Ackman prepared remarks; Q1 call, Ackman's introduction of Grandisson |
| Ben Hakim | director of | HHH | 2026-04-17 | 8K-GRANDISSON-26 — Item 5.02 |
| R. Scot Sellers | insider transaction | HHH | 2025-12-23 | FORM4-2025-26 — 0001104659-25-124903, Table I |
| HHH | issuer of | HHC 5.875% senior notes due 2032 and 6.125% senior notes due 2034 ($500m each) | 2026-02-17 | 8K-NOTES-26 — Item 1.01 |
| HHH | issuer of | HHH universal shelf, S-3ASR 2026-08-14 | 2026-08-14 | S3ASR-26 — Prospectus cover |
| KPMG LLP | auditor of | HHH | 2026-02-19 | 10K-2025 — Report of Independent Registered Public Accounting Firm |
| Wells Fargo & Company | holds | HHH | 2026-06-30 | 13F-Q2-26 — holders table, row 2 |
| BlackRock, Inc. | holds | HHH | 2026-06-30 | 13F-Q2-26 — holders table, row 3 |
| Sixth Street Partners Management Company, L.P. | context | HHH | 2026-06-30 | 13F-Q2-26 — holders table and the tool's duplicate warning |
| Charles Schwab Investment Management, Inc. | holds | HHH | 2026-06-30 | 13F-Q2-26 — holders table |
| HHH | context | HHH | 2026-09-23 | CLUSTER-HHH — §1 and §5 |
History 3 entries
- 2026-09-23 — first pass, run in a session on the owner's request, for slots
cluster-additions-2026-09-23andnames-additions-2026-09-23-1(HHH member only; 1913.HK run in parallel; schedule not edited by this pass). Stages: S0/S4/S6/S7 written toAdditions 2026-09-23 — HHH (Howard Hughes Holdings), industry stages, 2026-09-23; S1, S2, S3 (gate-minimum, two transcripts), S5 and S9 closed; S8 modelled and left open. Run finding: since 2026-06-04 HHH has owned a five-year-old specialty insurer (40% of assets) of which a Pershing Square fund's $1.0bn preferred takes up to 49%, whose float Pershing Square now manages without an additional fee and moved within weeks from bonds into a concentrated equity book (32% at 2026-06-30, ~40% by August, target >50%); S&P cut the insurer to BBB on the change of parent [search-summary]. S0 standard 3/4, §4.3 second reading on Vantage 0/2 applicable. No re-tag recommended now. Evidence and access indossier-2026-09-23.md. Nothing here is human-verified. - 2026-09-23 — stage redefinition, owner decision (WATCHLIST_PLAN.md §25): S8 is now Management credibility and is not yet run for this name; the old S8 valuation figures moved to the
valuation:line under S7, and any proposed buy price or position size was removed (the pipeline no longer drafts either). No research was redone. S2 capital allocation and S3 earnings quality are also pending, in the same backfill slot. - 2026-09-25 — backfill slot
backfill-2026-09-23-8, the three checks added on 2026-09-23 (WATCHLIST_PLAN.md §25). No other stage touched. S8 written: conservative — 9 rows, 6 beat, 2 met, 1 missed, 1 withdrawn, and every row belongs to executives still in the chair. Run finding: HHH withdrew its entire FY2026 guidance set on 2026-05-08, eleven weeks after publishing it on 2026-02-19, announced by the Executive Chairman rather than the CFO who gave it; there is no first guide for a future pass to score, and the one miss in the scored record — cash G&A at $108.6m against a $76-86m guide framed as an improvement — is on a line whose 2026 replacement guide excludes the Pershing Square variable fee. S2 gained its capital-allocation table: verdictneutral— buybacks at a $95.11 average now ~32% underwater at $64.58, against 9.0m shares issued at $100.00 versus $55.40 of book which lifted BVPS 14.8%; ROIC 2.2-6.1%, nearer 1.9% once capitalised interest is expensed; BVPS still below its 2022 level. S3 gained its earnings-quality check: 3 flags + 1 note, led by 46.7% of interest incurred being capitalised — $148.8m, or 120% of net income — and by the guided AOCF metric resting on the post-capitalisation interest line. The dodge log was re-read and is unchanged. Thin evidence: balance-sheet XBRL at this CIK begins at 2022-12-31, so the return and book-value series are four years rather than five, and the predecessor issuer's filings were not read to fill the gap. One market data call (price); no Equibles call was spent. Locators indossier-2026-09-25.md. Nothing here is human-verified.
Full notes, 25 Sep 2026 15 min read
HHH — dossier 2026-09-25 (backfill slot backfill-2026-09-23-8)
Model-drafted, unattended, by the cloud research routine. Nothing here is human-verified. Scope: only the three checks added on 2026-09-23 (WATCHLIST_PLAN.md §25) — S8 management credibility, S2 capital allocation, S3 earnings quality. Every other stage stands as written in dossier-2026-09-23.md and in _clusters/cluster-additions-HHH-2026-09-23.md.
Sources read this run, all free: SEC EDGAR XBRL companyfacts for cik 1981792; the 8-K Ex. 99.1 earnings releases of 2024-02-27 (0001628280-24-007196, the first FY2024 guidance), 2025-02-26 (0001628280-25-008123) and 2026-02-19 (0001628280-26-009701); the Item 5.02 8-Ks of 2025-05-06 and 2026-04-21; and all eight earnings calls in ledger/research/_transcripts/HHH/ (FY2024-Q3 through FY2026-Q2, market data). market data get_latest_stock_price was called once (NYSE:HHH, $64.58 at 2026-09-24). No Equibles call was made for this name — the 2026-09-23 pass had used Equibles for two transcripts; the archive covers eight.
Transcript guard: each of the eight files names its own fiscal quarter in its opening turn. None is mislabelled. market data renders the CEO as both "David O'Reilly" and "David R. O'Reilly", the CFO as "Carlos Olea" and "Carlos A. Olea", and the Executive Chairman as "William Albert Ackman"; it also expands "HHC"/"Howard Hughes" into "Howard Hughes Holdings Inc." inside quoted speech, which is why no sentence from those files is reproduced here as a verbatim company name.
A limitation that shapes two of the three sections. This CIK was created in the 2023 holding-company reorganisation. Its XBRL carries cash-flow items back to 2021 (the 10-K shows three years) but balance-sheet items only back to 2022-12-31. So the five-year uses-of-cash table below is complete and the return and book-value series are four years, not five. That is the same shape of gap the 2026-09-24 OMAB pass recorded, and it is recorded rather than filled from the predecessor issuer's filings, which this run did not read.
S8 — management credibility
Who was in the chair, from EDGAR
| Person | Role | Note |
|---|---|---|
| David R. O'Reilly | CEO | throughout the window; current |
| Carlos A. Olea | CFO | throughout the window; current — made every guidance row below |
| William A. Ackman | Executive Chairman from 2025-05-05 | 8-K 2025-05-06 (0001104659-25-044710); announced the removal of annual guidance a year later |
No CFO or CEO change in the window. The only Item 5.02 filings since 2025 are board seats, including the 2026-04-21 replacement of a Pershing Square designee. Every scored row below belongs to people still in the chair — which is unusual in this repository and makes the record directly load-bearing.
The say-vs-do table
Guidance is given in the fourth-quarter release and repeated by the CFO on the call; the locator for a written outlook is the 8-K accession, for a spoken one the call and its date.
| # | Promise (metric, period, figure) | Made by / where | Result / where | Verdict |
|---|---|---|---|---|
| 1 | FY2024 MPC EBT to decline 10–15% YoY, mid-point ~$300m | Carlos A. Olea, CFO — 8-K Ex. 99.1 of 2024-02-27 | $349.1m — AOCF table, 8-K Ex. 99.1 of 2026-02-19 | beat (+16% on the mid-point; the decline never happened) |
| 2 | FY2024 Operating Assets NOI up 1–4% YoY, mid-point ~$250m | Carlos A. Olea, CFO — 8-K Ex. 99.1 of 2024-02-27 | $257.0m, +6% — same table | beat (above the top of the range) |
| 3 | FY2025 MPC EBT up 5–10% YoY, mid-point ~$375m | Carlos A. Olea, CFO — FY2024-Q4 call, 2025-02-27, and the 2025-02-26 release | $476.1m, +36% | beat (+27% on the mid-point) |
| 4 | FY2025 Operating Assets NOI flat to +4%, mid-point ~$262m | Carlos A. Olea, CFO — same | $276.3m, +7.5% | beat (above the top of the range) |
| 5 | FY2025 condo revenue ~$375m with no gross profit (Ulana, a workforce tower) | Carlos A. Olea, CFO — same | $370.2m revenue; adjusted condo gross profit $0.7m | met — revenue inside 1.3%, profit nil as stated |
| 6 | FY2025 cash G&A $76–86m, mid-point $81m, framed as an improvement on 2024's $83m | Carlos A. Olea, CFO — same | $108.6m (G&A $122.2m less $13.6m non-cash stock compensation) — Cash G&A table, 8-K Ex. 99.1 of 2026-02-19 | missed — 26% above the top of the range and 31% above the prior year on a line guided to fall |
| 7 | FY2025 adjusted operating cash flow $320–375m, mid-point ~$350m (~$7/share), a metric introduced for 2025 | Carlos A. Olea, CFO — same | $446.4m | beat (+27% on the mid-point) |
| 8 | End 2025 with approximately $600m of cash | Carlos A. Olea, CFO — FY2024-Q4 call, 2025-02-27 | $1,468.5m reported (XBRL), of which $862.8m is the 2025 equity issuance to Pershing Square that the guide did not contemplate; $605.7m without it | met |
| 9 | The entire FY2026 guidance set — adjusted operating cash flow $415–465m, MPC EBT $343–391m, Operating Assets NOI $279–290m, condo revenue $720–750m at a $108–128m profit and 15–17% margins, cash G&A $82–92m | Carlos A. Olea, CFO — 8-K Ex. 99.1 of 2026-02-19 and the FY2025-Q4 call | Withdrawn eleven weeks later. William A. Ackman, Executive Chairman, FY2026-Q1 call, 2026-05-08: the earnings release no longer includes annual guidance; given the pending Vantage acquisition the company has elected to remove annual guidance expectations and will shift to longer-term objectives by platform. He added that but for the transaction the company would have raised the MPC EBT guide | withdrawn — counted here as one row, being one decision, and separately as five below |
Scored: 9 rows — 6 beat, 2 met, 1 withdrawn, and 1 missed (row 6). Counting the FY2026 withdrawal as the five separate metric guides it removed, the count becomes 13 rows — 6 beat, 2 met, 1 missed, 5 withdrawn, i.e. 46% withdrawn or missed, just under the half that §25 makes over-promises. Both counts are given because the verdict is sensitive to which one is used, and an unattended run should not choose the flattering one silently.
What the record actually says
The guidance was set to be beaten, and management says so out loud. Every segment guide in two consecutive years came in above the mid-point, three of them above the top of the range, and the 2024 MPC guide called for a 10–15% decline against a year that delivered +2%. On the FY2026-Q1 call Ackman gave the reason in his own words — the company would not want management thinking it had put out a guidance number it then had to make, even at the cost of discounting land to get there. That is a defensible philosophy and it is also the definition of conservative guidance under §25: beats or meets nearly every first guide.
The exception is the cost line, and it is not a rounding error. Cash G&A was guided to improve to $76–86m and came in at $108.6m — 26% above the top of the range and 31% above the prior year. The 2026 guide of $82–92m then disclosed why: it includes $15m a year of base fees paid to Pershing Square and excludes the variable fees, which the CFO described as based on quarter-end stock prices and difficult to predict. A company can only miss its own expense guide by a quarter of its range so long as the beats on revenue metrics keep covering it, and 2025's beats did — adjusted operating cash flow beat by $96m against a $27m G&A overrun.
And then the framework itself was removed. The 2026 guides were published on 2026-02-19 and withdrawn on 2026-05-08. The stated reason — a pending acquisition that closed on 2026-06-04 and changes what the company is — is real. The consequence is also real and belongs on the scorecard: from FY2026 onward HHH publishes no annual guidance, so there is no first guide for a future S8 pass to score. Row 9 is the last checkable promise this name has made. Everything after it is "longer-term objectives by platform", which is not a promise under §25 (no number tied to a period). The withdrawal was announced by the Executive Chairman, not by the CFO who had given the guides eleven weeks earlier.
Dodge log — carried forward, nothing added
The 2026-09-23 pass read the Q1 and Q2 2026 calls and logged three dodges, with a two-quarter thread on capital allocation between the real estate and Vantage. This run re-read those two calls in the §3.1 order and found nothing to add or correct; the FY2026-Q1 and FY2026-Q2 entries stand as written. The thread is unchanged: two quarters, one of the two askers retail, the S9 trigger already written.
S8's roll-up of that log: the dodged topic is how capital is split between the two businesses, and it is dodged in the same window in which management stopped publishing the numbers that would have answered it. Those two facts are independent — the dodges are Q1 and Q2 2026, the withdrawal is Q1 2026 — but they point the same way, and together they are why this name's monitoring now depends on filings rather than on management's own reporting.
Verdict
conservative, with two qualifications the scorecard carries.
- 6 beats and 2 meets in 8 scoreable operating rows, several above the top of the range, on guides the Executive Chairman has explicitly said are not meant to be managed to. Every row belongs to executives still in the chair.
- Qualification 1: the one miss is the expense line, missed by 26%, and the 2026 replacement guide for the same line excludes a related-party fee whose size the company says it cannot predict.
- Qualification 2: the record ends here. Annual guidance was withdrawn on 2026-05-08 and no future pass can score a first guide against a result. A conservative verdict on a company that has stopped guiding is a statement about the past tense, and it should be read that way.
Because the verdict is conservative and not over-promises, the S7 valuation table's base case is not haircut for management's guide (§25).
S2 — capital allocation and returns
All figures from SEC XBRL companyfacts, cik 1981792, as filed. Cash-flow lines run 2021–2025; balance-sheet lines run 2022–2025 (see the limitation note at the top).
Where the cash went
| $m | 2021 | 2022 | 2023 | 2024 | 2025 | 5y total |
|---|---|---|---|---|---|---|
| Operating cash flow | (284.0) | 325.3 | (258.5) | 396.6 | 462.4 | 641.8 |
| Real-estate development (investing line) | (274.7) | (268.4) | (231.0) | (253.0) | (171.0) | (1,198.1) |
| Buybacks | (81.1) | (403.9) | — | — | — | (485.0) |
| Dividends | — | — | — | — | — | — |
| Common stock issued | — | — | — | — | 862.8 | 862.8 |
| Stock-based compensation (non-cash) | 9.9 | 11.9 | 16.4 | 16.0 | 19.8 | 74.0 |
| Interest capitalised (non-cash to P&L) | 71.8 | 89.7 | 109.5 | 151.6 | 148.8 | 571.4 |
| Acquisitions, cash paid | — | — | — | — | — | — |
Read the operating line carefully. For a condominium developer, tower construction runs through operating cash flow, which is why 2021 and 2023 are negative — they are the Victoria Place and Ward Village build years — and why 2024 (Victoria Place closing, $778.6m of condo revenue in Q4 alone) is strongly positive. The investing line above is the income-producing portfolio, not the condo build. Five-year operating cash flow of $641.8m is therefore a net figure after roughly a tower cycle, not a run rate.
No dividend has been paid in the window, and no business was bought for cash. Vantage closed 2026-06-04, outside it, and was paid for with ~$900m of new HHH stock and a $1.0bn Pershing Square preferred (2026-09-23 dossier), not cash.
Did the buybacks more than offset the compensation, and at what price
- Treasury stock at 2022-12-31: 6,424,276 shares at a cumulative cost of $611.0m — an average of $95.11 a share. $485.0m of that cost, 79%, was incurred in 2021–2022 ($96.6m and $388.4m of repurchases). Treasury has barely moved since ($620.1m at 2025-12-31).
- Against $64.58 (NYSE:HHH, 2026-09-24, market data), the repurchased stock is about 32% underwater.
- Diluted weighted-average shares: 54.649m (2021) → 56.046m (2025). Shares outstanding 49.80m (2022) → 59.37m (2025). The buybacks did not survive the issuance.
The offsetting fact, and it is the better half of the record. The 9.0m shares issued to Pershing Square in 2025 were issued at $100.00, against a book value per share of $55.40 at 2024-12-31 — roughly 1.8x book. Book value per share rose from $55.40 to $63.59 in that year, +14.8%, and stood at $66.39 at 2026-06-30. HHH bought its own stock at ~$95 and sold it at $100 into a book of $55. The sequencing is the right way round, which is rare enough to say plainly, and it is why this section does not end in destroys.
Returns on the capital
Invested capital as equity plus long-term debt less cash; NOPAT as operating income at 21%. Four years, for the reason at the top.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Operating income ($m) | 424.2 | 216.2 | 559.9 | 331.5 |
| NOPAT at 21% ($m) | 335.1 | 170.8 | 442.3 | 261.9 |
| Invested capital ($m) | n/d (debt not tagged) | 7,666.2 | 7,307.1 | 7,417.0 |
| ROIC | — | 2.2% | 6.1% | 3.5% |
| Adjusted operating cash flow ÷ invested capital | — | — | 7.3% | 6.0% |
| Book value per share | $71.09 | $59.81 | $55.40 | $63.59 |
Every one of those returns is flattered by the capitalised-interest line, which the earnings- quality section below sizes: $148.8m in 2025, 46.7% of all interest incurred. Expense that interest and 2025's NOPAT falls by about $118m after tax and ROIC drops from 3.5% to roughly 1.9%. That is not an accusation — capitalising development interest is standard and audited — it is the statement that this business's reported return is a function of how much of its interest sits on the balance sheet.
Impairments in the window: $672.5m in 2023 (Seaport, before the July 2024 spin-off) and $15.3m in 2021. No goodwill impairment. Book value per share has not recovered its 2022 level.
Verdict: neutral
Not compounds: book value per share is $63.59 against $71.09 in 2022, the $485m of buybacks are 32% underwater, ROIC has not exceeded 6.1% in four years and is nearer 2% once capitalised interest is expensed, and $672.5m was written off in 2023.
Not destroys: the single largest capital act of the window — issuing 9.0m shares at $100 against $55.40 of book — created book value per share; the operating engines have compounded through it (MPC EBT $349.1m → $476.1m, Operating Assets NOI $257.0m → $276.3m); no cash has been spent on acquisitions; and no dividend has been paid out of a business that reinvests into land it already controls.
Per §25 a neutral verdict adds no kill criterion and does not change S2's glyph, which stays ✅ (the kill test is unchanged). The question this verdict does not answer — and the one the dodge log says management has twice declined to answer with a number — is what the next dollar earns, now that it goes to Vantage rather than to land. That is S7's and S9's problem, and the existing kill criteria already point at it.
Earnings quality
Written as §25 requires: each finding with its locator; a clean result says so.
Three flags and one note.
- Nearly half of all interest cost goes onto the balance sheet, and it is larger than net income. Interest capitalised (XBRL
InterestCostsCapitalized) against interest expensed (InterestExpenseNonoperating):
| $m | 2023 | 2024 | 2025 |
|---|---|---|---|
| Interest expensed | 157.6 | 164.9 | 169.9 |
| Interest capitalised | 109.5 | 151.6 | 148.8 |
| Capitalised share of interest incurred | 41.1% | 47.9% | 46.7% |
| Net income attributable to common | (551.8) | 197.7 | 123.9 |
In 2025 HHH capitalised $148.8m of interest against $123.9m of net income — 120%. This is ordinary development accounting and the auditor (KPMG since 2022) has not qualified it. It is a flag because of its size relative to the earnings line: the reported profit of this company is decided as much by how much interest is capitalised as by what the assets earn.
- The metric guidance was given on is built on the post-capitalisation interest line. Adjusted Operating Cash Flow is defined in the 8-K Ex. 99.1 of 2026-02-19 as MPC EBT plus Total Operating Assets NOI plus adjusted condo gross profit plus cash G&A plus net interest expense — the reported figure, after capitalisation. The $148.8m never enters it. AOCF was $446.4m in 2025 against $123.9m of GAAP net income, a 3.6x gap, and AOCF is the number three of the eight scored S8 rows above were set and judged on.
- The guided expense line excludes a real related-party cash cost. The FY2026 cash G&A guide of $82–92m includes the $15m annual base fee paid to Pershing Square and excludes the variable fee, which the CFO described on the FY2025-Q4 call as based on quarter-end stock prices and difficult to predict (his words; the exclusion is stated in the same turn). This is the same line that missed its 2025 guide by 26%.
Note, short of a flag. Adjusted condo gross profit is defined to exclude "costs ... related to the remediation of construction defects at Waiea tower and costs related to a settlement agreement reached for the reimbursement of Waiea remediation costs" — $15.1m in 2024, nil in 2025 (8-K Ex. 99.1 of 2026-02-19). A construction-defect remediation defined out of a margin measure is worth watching if the amount returns; at nil in the latest year it is not yet a flag.
Clean, with the number:
- Stock-based compensation is small. $19.8m in 2025 = 1.3% of revenue ($1,474.9m) and 4.4% of adjusted operating cash flow.
- Accruals are negative, i.e. conservative. (Net income − operating cash flow) ÷ average total assets: −2.1% (2024), −3.4% (2025). Operating cash flow against net income: 2.0x (2024), 3.7x (2025).
- No goodwill and no acquisition accounting in the window — the 2023 charge was a real-estate impairment at Seaport, disclosed and taken before the spin-off.
- Working capital in the classic receivables/inventory sense is not the right test for a developer: the equivalent is the condo backlog, which the 2026-09-23 pass recorded at ~$5bn of presold future revenue with an estimated $1.3bn of profit at a 25% margin, 87–96% presold.
Sector equivalent (§25 test 6), newly applicable. Since 2026-06-04 HHH owns an insurer, so prior-year reserve development is now part of this check. The only disclosure to date is $19m of adverse prior-year development in one quarter (Q2 2026, per the 2026-09-23 dossier), and Vantage has no loss-development table in HHH's filings yet. One quarter is not a series. The first checkable point is the FY2026 10-K, which is already this name's ➡️ Next action and its first kill criterion. The earnings-quality check is therefore recorded as done for the real-estate company and not yet possible for the insurer, which is a finding rather than a skip.
EQ summary line for the scorecard: EQ: 3 flags + 1 note — 46.7% of interest incurred is capitalised ($148.8m in 2025 = 120% of net income), the guided AOCF metric is built on the post-capitalisation interest line (AOCF $446.4m vs net income $123.9m), and guided cash G&A excludes the Pershing Square variable fee. SBC 1.3% of revenue and accruals −3.4% are clean. Vantage has no loss-development table yet — FY2026 10-K is the first checkable point.
What this run changed on the scorecard
- S8 ⬜ → ✅ conservative — 9 rows: 6 beat, 2 met, 1 missed, 1 withdrawn (13 and 46% withdrawn-or-missed if the FY2026 withdrawal is counted as its five metric guides). Every row belongs to executives still in the chair. ⚠️ annual guidance was withdrawn on 2026-05-08 and there is no first guide for a future pass to score.
- S2 keeps its ✅ glyph and gains the capital-allocation table and the verdict neutral. No kill criterion is added (§25 requires one only for an over-promiser or a capital destroyer).
- S3 keeps its ✅ (gate-minimum) glyph and gains the
EQ:summary above. - Dodge log unchanged — re-read and confirmed, nothing added.
- S7 valuation base case is not haircut: S8's verdict is conservative.
- ⚠️ failed-gates line updated with the guidance withdrawal.
Full notes, 23 Sep 2026 19 min read
HHH — Howard Hughes Holdings Inc. — dossier, 2026-09-23
Run in a session on the owner's request, following .claude/skills/stock-sourcing-pipeline/SKILL.md. It covers the name-pass stages of slot names-additions-2026-09-23-1, for HHH only (1913.HK is run in parallel by another session). Model-drafted; nothing here is human-verified. Sourced facts carry the document they were read from; [background] marks background knowledge and [search-summary] marks search-result evidence. Transcript content is paraphrased, never quoted. Private: this directory never reaches dist/.
Industry stages (S0, S4, S6, S7) are in _clusters/cluster-additions-HHH-2026-09-23.md.
Access this run
threespread.py check: OK — key present (len 46), HTTP 200 from api.3spread.com.- SEC EDGAR: reachable with the
User-Agentintools/edgar.py; filings saved as text in the session scratch directory. - Equibles: reachable. 3 calls spent (Q2 2026 transcript, Q1 2026 transcript, short interest).
- market data: prices (1 call).
- WebSearch: 2 queries.
§1 — S1 Source
watchlist (owner, 2026-09-23 addition, WATCHLIST_PLAN.md §24). Row added to watchlist.yaml on 2026-09-23 with CIK 1981792 and cluster holding_co. No Tier 0 promotion. No board claim rows. Predecessor issuer for the pre-2023 history: The Howard Hughes Corporation, CIK 1498828 (XBRL companyfacts carries both; the holding-company reorganisation put HHH above it in 2023, and HHC is now the wholly owned real-estate subsidiary and issuer of the senior notes).
§2 — S2 Kill test
| 2021 | 2022 | 2023 | 2024 | 2025 | H1 2026 | |
|---|---|---|---|---|---|---|
Revenue $m (XBRL Revenues) | 1,427.9 | 1,608.5 | 1,024.1 | 1,750.7 | 1,474.9 | 1,358.2 |
| Operating income $m | 241.9 | 369.1 | −528.2 | 559.9 | 331.5 | — |
| Net income $m | — | 184.5 | −551.8 | 197.7 | 123.9 | 165.0 |
| Diluted EPS | 1.03 | 3.65 | −11.13 | 3.96 | 2.21 | 2.82 |
| Operating cash flow $m | −284.0 | 325.3 | −258.5 | 396.6 | 462.4 | 277.1 |
| Diluted wtd shares m | 54.6 | 50.6 | 49.6 | 49.9 | 56.0 | ~59.1 (Q2) |
| Stockholders' equity $m | 3,710.0 | 3,540.5 | 2,992.9 | 2,776.2 | 3,775.5 | 3,960.4 |
| Debt $m (carrying) | 4,639 | 4,802 | 5,353 | 5,168 | 5,144 | 5,456 |
| MPC EBT $m (10-K) | — | — | — | 349.1 | 476.1 | 219.1 |
| Operating Assets NOI $m (10-K) | — | — | — | 245.5 | 262.0 | — |
Sources: XBRL companyfacts (CIK 1981792, with 2017–2021 continuity from CIK 1498828); FY2025 10-K MD&A for MPC EBT and NOI; Q2 2026 10-Q for H1 2026 and the balance sheet. Q2 diluted count derived as $158.4m / $2.68. 2023's loss and 2024's equity step-down include the Seaport write-downs and the 2024 spin-off of Seaport Entertainment Group [background for the attribution; the 10-Q names the spinoff]. Dashes: not extracted this run.
Revenue is lumpy by construction — condominium closings arrive tower by tower (527 units at The Park Ward Village in Q2 2026 alone lifted Strategic Developments EBT to $126.6m, 10-Q). The steady lines are Operating Assets NOI ($245.5m → $262.0m) and MPC EBT ($349.1m → $476.1m, +36%).
Margins. MPC is the profit engine: Q2 2026 MPC EBT $134.7m on $171m of land sales revenue (10-Q). Operating Assets EBT is negative after depreciation and interest (−$27.4m in 2025, 10-K) — the NOI is real, the property-level leverage absorbs it.
Debt and maturity wall. Carrying debt $5.46bn at 2026-06-30. Corporate senior notes after the February 2026 refinancing: $650m 4.125% due 2029, $650m 4.375% due 2031, $500m 5.875% due 2032, $500m 6.125% due 2034 (10-Q forward-looking list; 8-K 2026-02-17); the $750m 5.375% 2028 notes were redeemed at 100.896 on 2026-02-19 (8-K 2026-02-04). Bridgeland secured notes due 2029: $85m drawn, $515m undrawn. The rest is property-level, mostly non-recourse; at year-end $2.1bn of the $5.1bn was recourse (10-K Item 1A). Near-term wall: none at corporate level before 2029. The company's non-GAAP net debt was $3.28bn at 2025 year-end (10-K; includes JV share, nets cash and MUD/SID receivables) and $2.85bn at 2026-06-30 on the 10-Q's narrower definition — but that $2.85bn nets $1.9bn of cash held at Vantage (10-Q footnote), which is insurance float backing reserves and restricted by the Delaware approval (dividends from the Delaware insurers need prior approval until 2028-06-04). Read net debt ex-Vantage: roughly $4.75bn, computed as $5.46bn gross less the $0.71bn of cash outside Vantage (the 10-Q's $2.65bn less its $1.9bn). Against 2025 Operating Assets NOI plus MPC EBT of ~$0.74bn that is ~6.4x — the leverage of a property company, not of an insurance holding company. ⚠️ Covenant note: "As of June 30, 2026, the Company was not in compliance with certain property-level debt covenants." (10-Q, Debt Compliance); the effect is restricted excess cash at those properties, which the 10-Q says did not affect liquidity.
Share count over five years. Cover-page shares outstanding 55.1m (Feb 2021) → 49.8m (Feb 2023) → 50.4m (Feb 2025) → 59.4m (Jul 2025) → 59.7m (Aug 2026) (XBRL dei; 2026 proxy record date 59,719,462). Buybacks of $81.1m (2021) and $403.9m (2022) shrank it; the 9.0m shares sold to Pershing Square at $100 on 2025-05-05 grew it by 18% (8-K 2025-05-06). Net over five years: +8%. Outstanding dilution: Grandisson's warrants over 1,131,273 shares at $100 (exercisable 2030) and the Series A preferred, which exchanges into the insurance subsidiary, not into HHH common.
FCF. Operating cash flow was negative in 2021 and 2023 and $325–462m in the three other years; H1 2026 +$277.1m on the Park Ward Village closings. Management guides to $2.5–3bn of excess cash over five years from the real estate (both calls, paraphrased; a company target).
Analyst coverage count: J.P. Morgan, Piper Sandler and BMO asked questions in Q1; J.P. Morgan, Piper Sandler and KBW in Q2 (plus individual investors). Four firms on the calls; a formal count was not pulled.
Survives or dies: survives. No corporate maturity before 2029, $2.6bn of cash (of which $1.9bn at Vantage), positive operating cash flow, land that keeps selling. ⚠️ What survives is a leveraged real-estate company funding an insurer: ex-Vantage net debt is ~6.4x the two steady profit lines, and the Vantage cash that makes the consolidated net debt look lower is not available to the parent.
§3 — S3 Filings (gate-minimum)
Read: FY2025 10-K Item 1 (overview, strengths), Item 1A (industry, strategy/Pershing Square and financial risks) and Item 7 (highlights, MPC, net debt); Q2 2026 10-Q Notes 1–4 (AdVantage, Vantage acquisition and purchase-price allocation, Pershing Square, investments), MD&A (overview, highlights, Vantage results, liquidity, insurance-specific considerations), Item 3 (equity price risk), Item 1A (amended and new risk factors); 2026 DEF 14A ownership table and CD&A; 8-Ks listed in the cluster file §0; the S-3ASR cover; the EDGAR filing index for red flags; Q1 and Q2 2026 call transcripts.
The three biggest risks management discloses, in its own words
- Control by Pershing Square. > "Pershing Square has the ability to influence our policies and operations and its interests may not in all cases be aligned with other stockholders." > — FY2025 10-K, Item 1A, Risks Related to Our Holding Company Strategy and Our Relationship with Pershing Square, first heading
Sized: 46.6% of common (2026 proxy), voting capped at 40% on board-recommended matters and ownership capped at 47% under the standstill (8-K 2025-05-06); Pershing Square also holds the $1.0bn preferred in the insurance holding company and manages Vantage's float (10-Q Note 3).
- The strategy change and the insurer. > "Our recent shift in business strategy, including the planned acquisition of Vantage, will create additional and different risks than those we face in our existing real estate business." > — FY2025 10-K, Item 1A, same section, second heading
And the 10-Q's new factor on the insurer's history: > "Vantage was founded in late 2020 and accordingly has a relatively short operating history." > — Q2 2026 10-Q, Part II Item 1A, Risks Related to Our Insurance Operations
With, on the asset side, the new investment-portfolio risk factor's phrase that "adverse investment results may coincide with underwriting losses" (same Item 1A).
- Housing. > "A downturn in the housing market or decline in general economic conditions could adversely affect our business, financial condition, and operations." > — FY2025 10-K, Item 1A, Risks Related to Our Industry, Market, and Customers, second heading
Fourth, because the leverage is a property company's:
"We have a substantial amount of indebtedness, a significant portion of which will mature in the coming years." — FY2025 10-K, Item 1A, Financial Risks (restated in the Q2 2026 10-Q)
Latest-quarter delta (Q2 2026 10-Q MD&A)
- Net income to common $158.4m (Q2 2025: −$12.1m): 527 condo closings at The Park Ward Village, $51.8m gain on two Woodlands multifamily sales, MPC EBT $134.7m (+32%), less a $20.8m pre-tax loss at Vantage in its 26-day stub (a $38.3m investment loss, mostly $36.0m unrealised on the new equity sleeve, and $20.2m of VOBA amortisation).
- Vantage stub: GWP $156.1m, NWP $107.2m, NEP $97.2m; loss ratio 56.8%, expense ratio 38.4%, combined 95.2%, which the 10-Q says is not representative.
- Balance sheet: total assets $10.64bn → $15.91bn; claim reserves $2.12bn; unearned premium $1.41bn; goodwill $282.2m and intangibles $586.4m (of which VOBA $304m, 90% amortised in year one — a drag on reported insurance earnings through mid-2027); mezzanine preferred $995.8m.
- Liquidity: $2.6bn cash including Vantage; $970.3m undrawn development commitments.
- No 10b5-1 plan adopted or terminated by any director or officer in the quarter (10-Q Item 5).
Capital actions on file
- Pershing Square common purchase: 9.0m shares at $100, $900m, 2025-05-05, with the services, shareholder, standstill and registration-rights agreements (8-K 2025-05-06).
- Pershing Square advisory fee: "The Company will pay Pershing Square a quarterly base fee of $3,750,000 and a quarterly variable fee equal to 0.375% of the excess value of the quarter-end stock price of the Common Stock minus the reference price of $66.1453, multiplied by existing share count of 59,393,938 shares" (8-K 2025-05-06). Base $15m a year, PCE-indexed; the variable fee is ~$0 at $66 and ~$30m a year at $100 (computed). Fees recognised: $7.6m in H1 2026 (10-Q Note 3). Ten-year initial term with ten-year renewals; a change-of-control termination pays a make-whole of the remaining fees.
- Series A non-voting exchangeable perpetual preferred: 140,000 shares to Pershing Square Holdings, Ltd. for $1.0bn, 2026-06-04 (8-K 2026-06-05; Form 4 of 2026-06-08 at $7,142.86 a share). Dividends only if the disinterested directors declare them, and capped: "Such declared dividends may not exceed the pro rata cash dividends or distributions actually received by the Company from Vantage (through Buyer)." Exchange into insurance-holding units from 60 days after the seventh fiscal year (FY2032); HHH call 60–90 days after each of the first seven fiscal year-ends at the greater of 4% accretion and 1.5x tangible book; mandatory repurchase offer on a change of control; 10% default dividend if a required repurchase is not paid.
- Notes refinancing: $1.0bn of 2032/2034 notes issued 2026-02-17 to redeem the $750m 2028 notes; the balance funded the Vantage closing (8-K 2026-02-04, 2026-02-17).
- Grandisson warrants: $10m paid for warrants over 1,131,273 shares at $100, exercisable 2030-04-20 (8-K 2026-04-21).
- Universal shelf: S-3ASR filed 2026-08-14 — debt, common, preferred, warrants, units, amount unlimited by construction. No takedown. Filed eight days after the executive chairman said issuing equity near current prices would not be intelligent (Q2 call, paraphrased); a WKSI shelf is also routine housekeeping, and Pershing Square's subscription rights attach to any common issuance.
- Buyback: the March 2022 $250m authorisation, $235.0m used in 2022, remains open; no purchases since (10-Q Note on common stock).
Proxy skim (2026 DEF 14A, meeting 2026-09-30)
- Insider ownership: all directors and executive officers as a group (17 persons) 28,460,906 shares, 47.7% — of which Ackman's attributed Pershing Square holding is 27,852,064 (46.6%). Excluding Pershing Square, insiders own ~608,842 shares, ~1.0%. CEO David O'Reilly 227,439.
- What the bonus is paid on: 75% on Operating Assets NOI ($262.0m vs $247.0m target, 106%), MPC EBT ($476.1m vs $472.4m, 101%), condominium profit and corporate cash G&A; 25% individual. CEO 2025: $1.0m salary, $2.1m bonus, $4.68m long-term equity. Nothing in the 2025 scorecard measures Vantage, book value per share or return on capital — the metrics are the old real-estate ones, and the MPC EBT target was set only $3.7m below the result.
- Executive Chairman and CIO are Pershing Square's Ackman and Israel, paid through the services agreement rather than by HHH (inferred from the structure; the proxy was not read for their line).
- Routine meeting: directors, say-on-pay, KPMG ratification. KPMG auditor "since 2022" (10-K auditor's report); the predecessor changed auditors by 8-K Item 4.01 in May 2022.
Insider pattern (3spread insiders --days 365 --limit 200, 54 filings; Form 4 XML read directly)
| Date | Insider | Code | Shares | Price |
|---|---|---|---|---|
| 2025-09-26 | Anthony Williams, director | S | 1,100 | $79.58 |
| 2025-11-26 | Mary Ann Tighe, director | S | 6,000 | $88.83 |
| 2025-12-23 | R. Scot Sellers, director | P | 5,000 | $77.94 |
| 2026-03-13 | Joseph Valane, General Counsel | P | 1,260 | $64.45 |
| 2026-03-25 | Andrew Davis, COO of HHC | S | 1,636 | $63.87 |
| 2026-04-21 | Pershing Square (PSLP → PS Redemption, L.P.) | J | 341,033 | $65.86 (ref.) |
| 2026-05-15 | James Carman, President Houston Region | S | 1,500 | $64.20 |
| 2026-06-04 | Pershing Square Holdings | A (preferred) | 140,000 | $7,142.86 |
| 2026-07-15 | Marc Grandisson, Executive Chairman of Vantage | A (restricted) | 68,653 | — |
Plus many tax-withholding (F) rows on 2025-12-31 and 2026-02-03/05 at $79.77–$80.04, and director grants on 2026-06-19. The Pershing Square "J" row is a transfer between its own vehicles for a special redemption of limited-partner interests (Form 4 footnote), not a sale. Pattern: immaterial. Two small open-market purchases, four small sales, no pattern either way. Form 144s (2025-11-26 through 2026-08-17, six) were not opened.
Red-flag sweep
- No NT 10-K / NT 10-Q for either CIK since 2011; no 10-Q/A. Two 10-K/As, both Part III only because the proxy came late (the 2026 one says so on its face).
- SEC comment-letter correspondence: last CORRESP/UPLOAD 2017 (predecessor); none on HHH.
- Auditor change: May 2022 (8-K Item 4.01, predecessor) to KPMG.
- Executive changes: Ben Hakim (Pershing Square) left the board 2026-05-07 and Marc Grandisson took the Pershing seat (8-K 2026-04-21); L. Jay Cross (President) retired 2025-09-16 with $4.57m of severance (2026 proxy); the 10-Q says Vantage has had several senior leadership changes since announcement. Its CEO-designate from Arch is under a non-compete until about June 2027 (Q2 call, paraphrased).
- Property-level covenant non-compliance (above).
- Going concern: not applicable on these numbers; not searched on Equibles to save budget.
Transcripts — Q1 2026 (2026-05-08) and Q2 2026 (2026-08-06), Equibles, read Q&A-first
Guidance and commentary changes (prepared remarks):
- Q1: annual guidance withdrawn because of the pending Vantage deal; replaced by new KPIs (MPC residual land value, operating-asset adjusted maintenance free cash flow, condo remaining profit). The CEO said Q1 land sales and MPC EBT were ahead of plan. The CIO put the company's conservative value at about $104 a share and a 2030 target at about $211 (a company estimate). Excess cash from real estate over five years: $2.5–3bn.
- Q2: Vantage-standalone Q2 combined ratio 101.6% ($18m cat losses tied to the Iran conflict, $19m adverse prior-year development largely in a discontinued transaction-liability line); H1 96.1%; current-year ex-cat 90.9% H1. A.M. Best affirmed A- with positive outlook; S&P's action described as a group-methodology result. Equity sleeve ~33% at quarter-end, ~40% five weeks later, target north of 50%; it was down ~3% at quarter-end and up 4–5% a month later per the CIO. New Vantage leadership: Grandisson as executive chair, an Arch co-president as CEO-designate. The real estate business will be pruned and partly financed with third-party capital; the stated direction is to become disproportionately an insurance holding company. Equity issuance at current prices ruled out by the executive chairman.
What the analysts asked about (by topic):
- Pershing Square's capacity and commitment — both calls (J.P. Morgan in Q1 on the Pershing Square listings; J.P. Morgan in Q2 on further support). Answered: Pershing is capped at 47% and calls HHH a permanent holding; further capital comes from real-estate monetisation.
- The value estimate — Q1 (Piper Sandler).
- Monetisation of real estate and competitive position inside the MPCs — Q1 (J.P. Morgan), Q2 (Piper Sandler).
- Data centres or other uses for the Phoenix land — Q1 (Piper Sandler).
- Whether the new KPIs reward holding land rather than selling it — Q1 (BMO).
- The Vantage investment portfolio and claims liquidity — Q2 (Piper Sandler).
- Underwriting targets, the cycle, reinsurance growth — Q2 (KBW, Meyer Shields). The equity return is not in the underwriting ROE target, per Grandisson — answered directly.
- Capital allocation between real estate and Vantage — Q1 (BMO), Q2 (an individual investor).
Dodges:
- Q1 2026 · value estimate down from $118 to $104 · Alexander Goldfarb (Piper Sandler). Asked whether the move from the previously disclosed $118 to $104 was the dilution from the $100 issue. The answer described why the method is conservative and said there is some dilution; it did not bridge the $14. Locator: Equibles Q1 FY2026 transcript, Goldfarb's second question.
- Q1 2026 · which real-estate investments are deferred to fund Vantage · John Kim (BMO). Asked what investments in the MPC business are now being deferred or removed. The answer gave the counterfactual that West Phoenix would have been $600m more into Vantage and the higher ROE of insurance; no project was named. Locator: Q1 transcript, Kim's second question.
- Q2 2026 · the hurdle a dollar must clear · individual investor (name garbled in the machine transcript). Asked what an opportunity has to clear to win capital now that real estate and Vantage compete. The answer said every incremental dollar goes to Vantage and described the equity market; no hurdle rate or comparison was given. Locator: Equibles Q2 FY2026 transcript, the individual-investor exchange after KBW.
Not asked, recorded: nobody asked about the S&P downgrade and withdrawal, the $19m of adverse development, or the 1.5x-book call price on the preferred. The chair's own description of the S&P action (group methodology) did not say "downgrade" or "withdrawn"; that is framing, not a dodge, because no question was put.
Thread: capital allocation between the land and the insurer was not answered with a number in Q1 or Q2 (one sell-side, one retail asker). Two quarters — flagged in the scorecard ⚠️ line and backed by an S9 trigger (the segment capital-contribution disclosure).
§4 — S5 Ownership
13F at 2026-06-30 (threespread.py holders HHH): Pershing Square Inc. 27,852,064 sh ($1,991.1m, i.e. $71.49 at 2026-06-30); Wells Fargo 1,807,568 (−1,253,188); BlackRock 1,619,333 (+139,898); Long Focus Capital 733,695; Flat Footed 620,418 (+405,130); Gotham 598,252 (+303,245); State Street 585,843; River Road 492,052; Citadel 469,862 (+307,962); Susquehanna 399,565; Jane Street 341,564.
- ⚠️ Ingestion incomplete: 195 filers for Q2 against 288 for Q1. Vanguard (3.30m + 3.01m at Q1), Dimensional (2.82m), American Century (1.24m), Donald Smith (1.04m), Geode, Franklin, Morgan Stanley have no Q2 13F ingested yet — not exits.
- ⚠️ The tool's
Exited since prior quarterline for Pershing Square Capital Management, L.P. (18,852,064 sh) is a change of reporting entity (the fund holding now reported under Pershing Square Inc., whose row shows +18,852,064), not an exit — the total is 27,852,064 on both the 13F and the proxy. - ⚠️⚠️ The Sixth Street row (190,306 sh, "NEW") is not a holding. It carries exactly Charles Schwab Investment Management's share count; 3spread flags the duplicate. Same filing defect as
ACGL/dossier-2026-09-22.md§5, NLY and KNSL. Not carried.
13D/G census (threespread.py owners HHH): Pershing Square's Schedule 13D/As on each capital event (2025-05-07, 2025-08-07, 2025-12-19, 2026-04-29, 2026-06-08); passive 13G/13G-As otherwise (latest 2026-07-31 for 2026-06-30). No other 13D.
Short interest: 3,544,116 shares at 2026-08-31 (FINRA via Equibles), up from 2,635,919 at 2026-06-30 — five consecutive increases; 8.3 days to cover. 5.9% of shares outstanding, 11.1% of the float outside Pershing Square. An Equibles model estimate for 2026-09-15 (~3.65m, low confidence) is not a FINRA figure and is not relied on.
Shelf / ATM / buyback: unlimited universal S-3ASR on file since 2026-08-14 (no takedown); no ATM found; $15m of the 2022 $250m buyback authorisation unused and dormant. Absence of an ATM in the filings read is not proof that none exists.
Who is on the other side: Pershing Square (46.6%, capped at 47%, 40% voting cap, a permanent holder by its own statement), index money, a handful of value managers, and multi-strategy and market-making desks that added in Q2 (Citadel, Jane Street, Susquehanna, HRT). Insiders outside Pershing own ~1%. The shorts hold 11% of the non-Pershing float.
§5 — S8 Valuation & sizing (model; buy price and size ⏳ OPEN (user))
HHH has no stable earnings line to multiply, and the company itself has moved to NAV-style KPIs. The model is book value per share at mid-2028 × a price-to-book multiple, with book built up from the three parts.
| Case | What happens by mid-2028 | BVPS mid-2028 | P/B | Value | vs $66.09 |
|---|---|---|---|---|---|
| Bear | Housing slows (MPC EBT back to 2024's ~$350m); Vantage books adverse development; the equity sleeve (~$1.5bn by then) falls 25% (−$375m pre-tax, about half passed to the preferred via the exchange formula) | ~$64 | 0.75 | ~$48 | −27% |
| Base | Retained earnings ~$5.5/share a year (H1 2026 run-rate $2.8/share, lumpy); equity sleeve earns ~8%; no issuance | ~$78 | 1.00 | ~$78 | +18% |
| Bull | Land and condos as guided; Vantage compounds book at mid-teens with the equity sleeve; market pays for the insurer | ~$80 | 1.40 | ~$112 | +69% |
Inputs: BVPS $66.39 at 2026-06-30 (common equity $3,960.4m / 59,657,062 shares, 10-Q balance sheet); tangible $51.83; H1 2026 net income to common $166.6m; equity sensitivity ±$107.8m per 10% (10-Q Item 3). The P/B multiples are assumptions. The base-case +18% has no dividend on top (HHH pays none). Not used: the company's $104 "conservative" value and $211 2030 figure (Q1 call), which rest on a land residual value and a deck not read here.
Proposed buy price ⏳ OPEN (user): at or below 0.85x the latest reported BVPS (~$56 on the 2026-06-30 book), and only once the FY2026 10-K shows the first Vantage loss-development table without adverse development. At today's 1.00x the market is paying full book for a structure whose upside above 1.5x tangible book in the insurer is shared with the preferred.
Proposed size ⏳ OPEN (user): liquidity is adequate but not deep — ADV $41.6m and only ~31.9m shares outside Pershing Square. A position building at ≤5% of ADV is ~$2m a day. The binding constraint is correlation: at 40–50% equities, Vantage's book tracks Pershing Square's portfolio, so size HHH as part of any Pershing Square exposure (PSH, PSUS) the owner already has, not beside it.
§6 — S9 Monitoring
- Next earnings: ~2026-11-05 to 2026-11-10 (DERIVED from cadence, not from a calendar): Q3 2025 was released 2025-11-10, Q1 2026 on 2026-05-07, Q2 2026 on 2026-08-05; the call follows the next morning. The annual meeting is 2026-09-30 (8-K/A 2026-08-11), routine items only.
- Filing feed: Tier 0 EDGAR sweep,
cik: 1981792on the watchlist row. Pershing Square's 13D/As are filed under HHH's CIK and will surface there too. - Leading indicator between quarters: Pershing Square's own published portfolio performance [background: PSH publishes NAV weekly] — the CIO said the Vantage sleeve holds largely the same names, so it marks Vantage's book before HHH reports. Second: Summerlin new-home sales and superpad pricing in the MPC quarterly supplemental.
- Trigger that converts it to a buy: price ≤0.85x latest reported BVPS and the FY2026 10-K's first Vantage loss-development table shows no adverse aggregate development and A.M. Best still A- (positive or stable).
- Thread trigger (from the dodge log): the Q3 10-Q or FY2026 10-K disclosing the capital contributed to Vantage and the real-estate development spend side by side. If capital keeps moving to Vantage with no stated hurdle, treat the allocation question as a kill-criterion candidate.
- Trigger that kills it: any of the five kill criteria in the cluster file §5.